openPR Logo
Press release

Tumour Ablation Devices Market 2016-2026 Analysis, Segments, Growth and Value Chain

08-31-2017 01:15 PM CET | Health & Medicine

Press release from: Future Market Insights

Tumour Ablation Devices Market 2016-2026 Analysis, Segments,

Tumours are the groups of abnormal cells that accumulate together and form lumps and grow consistently. Tumour are categorized into noncancerous and cancerous tumours. Precancerous conditions have the potential of developing into cancer. Tumour ablation is a tool utilized to treat cancerous malignancy. Tumour ablation is the process of removing the cancerous cells from the body. Tumour ablation became more useful during 1970s and 1980s due to advances in laparoscopic surgical approach. The most common means for definitive treatment of primary and metastatic focal malignancy, is the evolution of imaging devices during the past two decades and image-guided tumour ablation.

Tumour Ablation Devices Market: Drivers & Restraints

Increasing prevalence and incidences of cancers, technological advances and increasing geriatric population, increasing numbers of hospitals and healthcare awareness are facilitating the growth of global tumour ablation devices market. Additionally, economic pricing, short recovery time, low risk of infection, and minimal hospital stays are increasing the importance of tumour ablation devices.Side effects associated with ablation treatment and limited performance of the devices are the factors restraining the growth of global tumour ablation device market.

Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1325

Tumour Ablation Devices Market: Overview

The lung cancer application segment is expected to grow at the highest CAGR in the next five years due to large patient population of lung cancer present across developing and developed regions. This has increased the investment of manufacturers to develop and commercialize innovative lung cancer ablation products. The radiofrequency ablation is widely used technique due to specificity of treating target tissue without causing damage to the surrounding cells. Microwave ablation product segment is expected to grow significantly due to increase in adoption rate of microwave ablation devices by healthcare professionals.

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1325

Tumour Ablation Devices Market: Region-wise Outlook

Region wise, the global tumour ablation market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa.The global market is expected to be dominated by North America due to factors such as early introduction and adoption of rate of tumour ablation products in the region, trend of replacing older technologies and introducing the new technologies, and increase in private and public funding to develop and commercialize the novel tumour ablation products.The Asia-Pacific market is expected to grow at a higher CAGR in the forecast period due to factors such as large population with the high prevalence of various cancers in the region, government initiatives for developing and modernizing the healthcare infrastructure.

Tumour Ablation Devices Market: Key Players

Key players of tumour ablation devices market are Boston Scientific Corporation, St. Jude Medical, Inc., Biotronic NeuroNetwork, LLC, Baylis Medical, biolitec AG, Spectranetics, Esaote SpA, ALPINION MEDICAL SYSTEMS Co., Ltd., Chongqing Haifu Medical Technology Co., Ltd., Koninklijke Philips N.V, Hironic Co., Ltd., Monteris Medical, Inc, EDAP TMS, EYE TECH CARE, NeuWave Medical, Inc, Vison medical, AtriCure, Inc, Galil Medical Inc, ENDOCARE INC, IceCure Medical, Sanarus HealthTronics, Inc, MEDTRONIC, MedWaves, AngioDynamics, Microsulis Medical, Perseon, SympleSurgical Inc. to name a few.

ABOUT US: Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email:
press@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tumour Ablation Devices Market 2016-2026 Analysis, Segments, Growth and Value Chain here

News-ID: 693410 • Views:

More Releases from Future Market Insights

Tumor Profiling Market Size and Share Forecast Outlook From 2025 to 2035
Tumor Profiling Market Size and Share Forecast Outlook From 2025 to 2035
The Tumor Profiling Market is entering a transformative decade, driven by precision oncology, liquid biopsy advancements, advanced sequencing technologies, and growing demand for personalized cancer treatment. As leading companies like Thermo Fisher Scientific, Illumina, F. Hoffmann-La Roche AG, Bio-Rad Laboratories, and Agilent Technologies strengthen their product portfolios, the tumor profiling market is expected to witness sustained adoption across diagnostic laboratories, clinics, and hospitals. "Explore trends before investing - request a sample
Personalization Lead the Prescription Lens Market Share Analysis Growth Path
Personalization Lead the Prescription Lens Market Share Analysis Growth Path
The global Prescription Lens Market Share Analysis is entering a pivotal growth phase as aging populations, digital lifestyles, and advanced vision-care technologies reshape consumer needs. The market is projected to grow at a 3.7% CAGR and reach USD 62,666.2 million by 2035. As demand continues accelerating, leading brands are refining their strategies to serve evolving optical expectations. "Explore trends before investing - request a sample report today!" https://www.futuremarketinsights.com/reports/sample/rep-gb-20711 Market Momentum: What Is Powering
Peptide Microarray Market Growth Outlook to 2035: Innovation, Strategy, and Market Impact
Peptide Microarray Market Growth Outlook to 2035: Innovation, Strategy, and Mark …
The Peptide Microarray Market is entering a transformative phase driven by technology advancements, rising investment in proteomics, and expanding applications across diagnostics and drug discovery. According to projections, the peptide microarray market is set to reach USD 903.8 million by 2025, progressing steadily at a CAGR of 3.8% through 2035. Precision tools, proteomics infrastructure growth, and innovation in peptide profiling platforms continue to reshape the future of global healthcare innovation. Explore
Japan Cold Laser Therapy Market Size and Share Forecast Outlook From 2025 to 2035
Japan Cold Laser Therapy Market Size and Share Forecast Outlook From 2025 to 203 …
The Japan Cold Laser Therapy Market is set for steady expansion as healthcare providers, manufacturers, and end users shift toward advanced non-invasive treatment technologies. The (Japan Cold Laser Therapy Market) is projected to rise from USD 7.2 million in 2025 to USD 12.0 million by 2035, reflecting a CAGR of 5.2%. Cold laser therapy is gaining recognition due to its ability to reduce inflammation, promote healing, and alleviate pain-without requiring

All 5 Releases


More Releases for Tumour

Global Tumour-lnduced Osteomalacia Market Outlook Report 2025
Global Info Research announces the release of the report "Global Tumour-lnduced Osteomalacia Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides a detailed overview of the Tumour-lnduced Osteomalacia market scenario, including a thorough analysis of the Tumour-lnduced Osteomalacia market size, sales quantity, revenue, gross margin and market share.The Tumour-lnduced Osteomalacia report provides an in-depth analysis of the competitive landscape, manufacturer's profiles, regional and national market
Circulating Tumour DNA Market Size Report 2034
On April 25, 2025, Exactitude Consultancy., Ltd. released a research report titled "Circulating Tumour DNA Market". This report covers the global Circulating Tumor DNA market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends.
Innovation Unleashed: Circulating Tumour Cells Market Role in Market Expansion
Ignite growth in the 𝐂𝐢𝐫𝐜𝐮𝐥𝐚𝐭𝐢𝐧𝐠 𝐓𝐮𝐦𝐨𝐮𝐫 𝐂𝐞𝐥𝐥𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 sector with insights from Growth Market Reports ! Our comprehensive analysis provides a roadmap to success, offering key insights into market dynamics, opportunities, and outlooks. Harness the power of data-driven decision-making and unlock your business's full potential. Explore the frontier of 𝐂𝐢𝐫𝐜𝐮𝐥𝐚𝐭𝐢𝐧𝐠 𝐓𝐮𝐦𝐨𝐮𝐫 𝐂𝐞𝐥𝐥𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 possibilities with Growth Market Reports groundbreaking report! Uncover key insights into market dynamics and emerging trends that
Tumour Ablation Market Report Up to 2031
Visiongain has published a new report on Tumour Ablation Market Report 2021-2031: Forecasts by Technology (Radiofrequency, Microwave, Cryoablation, IRE, Ultrasound, Laser), Mode of Treatment (Surgical, Laparoscopic, Percutaneous), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/tumour-ablation-market-2021/#download_sampe_div Technological innovations in the area of tumor ablation combined with increased
Tumour Ablation Devices Market Forecast and Segments, 2016-2026
Tumours are the groups of abnormal cells that accumulate together and form lumps and grow consistently. Tumour are categorized into noncancerous and cancerous tumours. Precancerous conditions have the potential of developing into cancer. Tumour ablation is a tool utilized to treat cancerous malignancy. Tumour ablation is the process of removing the cancerous cells from the body. Tumour ablation became more useful during 1970s and 1980s due to advances in laparoscopic
Trends in the Tumour Ablation Devices Market 2016-2026
Tumours are the groups of abnormal cells that accumulate together and form lumps and grow consistently. Tumour are categorized into noncancerous and cancerous tumours. Precancerous conditions have the potential of developing into cancer. Tumour ablation is a tool utilized to treat cancerous malignancy. Tumour ablation is the process of removing the cancerous cells from the body. Tumour ablation became more useful during 1970s and 1980s due to advances in laparoscopic